NJ Top Doctors – Reproductive Medicine Associates of New Jersey
Scotch Plains – April 2013
2011 IVF SUCCESS RATES
IVF Delivery Rates of 64.4% in Women Under 35 — 24% Higher Than the National Average for 2011
Basking Ridge, NJ – April 1, 2013 For many people in New Jersey and elsewhere becoming pregnant or staying pregnant is not easy and filled with many emotions. Infertility affects millions of Americans but recent advancements in In-vitro fertilization (IVF), egg freezing, PGD, CCS, extended embryo culture, and trophectoderm biopsy are raising expectations for success and giving new hope to patients everywhere.
Reproductive Medicine Associates of New Jersey (RMANJ) which has offices in Basking Ridge, Eatontown, Englewood, Morristown, Somerset, Summit, and West Orange has recently released In-vitro fertilization (IVF) delivery rates for the year ending December 2011. RMANJ continues to outpace the nation with this latest data showing an IVF delivery rate per cycle initiated of 64.4% in women under 35 years of age. The US national average for the same period and age group is 40.1%.
The 2011 data is based on pregnancy and delivery rates of nearly 2,000 treatment cycles across all age groups.Information is governed by The Society of Assisted Reproductive Technology (SART), the primary organization of professionals dedicated to the practice of Assisted Reproductive Technologies in the United States. RMANJ’s full Clinic Summary Report can be viewed at www.sart.org.
RMANJ, a world-renowned leader in the field of Assisted Reproductive Technology (ART), credits the continued increase in successful pregnancies to their pioneering research in the areas of blastocyst embryo transfer, SelectCCS (Comprehensive Chromosome Screening), trophectoderm biopsy (TE) of embryos for genetic testing, and Single Embryo Transfer (SET).
Dr. Richard T. Scott, founding partner of RMANJ, says advancements like SelectCCS enable RMANJ physicians to transfer only the most viable embryo, increasing the likelihood of implantation and healthy delivery.
“Published data suggests that 50-70% of miscarriages are due to embryos with too few or too many chromosomes.At RMANJ, we’ve developed a one-of-a-kind, rapid 24-chromosome screening platform that can identify which embryos are euploid, or have the correct number of chromosomes,” he says. “Using this approach, we can then transfer only one healthy embryo if the patient chooses, eliminating the risk of multiple pregnancies and births, the most common and costly complication of IVF, while maintaining high success rates.”
Other centers have attempted similar embryo testing methods, but RMANJ is the only fertility center in the world to have developed a system of unprecedented accuracy, fully validated through years of rigorous clinical research, including the recent BEST (Blastocyst Euploid Selective Transfer) clinical trial. Further advancing RMANJ’s technique is its laboratory’s distinction as an exclusive blastocyst-transfer program, capable of allowing embryos to develop for five to six days prior to transfer.
“More time in the lab enables embryos the opportunity to amass higher numbers of cells, making them more viable for the embryo selection process and less susceptible to complications following testing,” Dr. Scott says.“With accuracy rates up to 98%1,2, SelectCCSis helping to redefine success in IVF.”
RMANJ’s commitment to stay at the forefront of pioneering reproductive medicine is based in the belief that continuous improvement is the key to enabling more patients to become parents.
“We have a singular goal of developing tomorrow’s technology today, to shape the future of our field,” says Dr. Thomas Molinaro from RMANJ’s Eatontown, NJ office. “This commitment easily translates into better outcomes for our patients.”
Dr. Shefali Mavani Shastri, who practices out of several of RMANJ’s offices including the Overlook Medical Center in Summit, says her patients truly benefit from the center’s unparalleled commitment to excellence, from the state of the art embryology laboratory to the exceptional clinical care. We strive to offer our patients the most cutting edge treatment in a compassionate, personalized setting.
Through our novel research and breakthrough technologies, we are redefining the way fertility medicine is being practiced today, with a focus on achieving the highest pregnancy rates and ensuring the safest pregnancies possible for our patients.”
About Reproductive Medicine Associates of New Jersey
The fertility experts at RMANJ have among the highest IVF success rates in the country, and consistently report pregnancy success rates above the regional and national average. The world-renowned RMANJ laboratory in Basking Ridge has been recognized by both competitors in the field and scientific institutions as a standard of excellence. Since 1999, they have helped bring more than 30,000 babies to loving families.In addition to serving as the Division of Reproductive Endocrinology at Robert Wood Johnson University Medical School in New Brunswick, NJ, the practice has seven locations in New Jersey.
Treff N, Su J, Tao X, Miller K, Scott RT Jr. First IVF babies born after rapid 24 chromosome embryo aneuploidy screening and fresh embryo transfer. Fertil Steril 2009a;92:S49.
Forman, E.J., Tao, X., Ferry, K.M., Taylor, D., Treff, N.R., Scott, R.T. Single Embryo Transfer with Comprehensive Chromosome Screening Results in Improved Ongoing Pregnancy Rates and Decreased Miscarriage Rates. Human Reproduction. April 2012; 27(4):1217-22.
Reproductive Medicine Associates of New Jersey are conveniently located in Basking Ridge, Morristown, Eatontown, Englewood, Somerset, Summit and West Orange, New Jersey.
For more information and locations you can visit Reproductive Medicine Associates of New Jersey’s s full profiles at
NJ Top Docs is a comprehensive information resource of Top Doctors, Dentists and Hospitals. We are profiling over 900 Healthcare Providers and have made it convenient for you to find them.
NJ Top Docs allows patients to “meet” these providers online before making their appointment.